nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—PTGS1—kidney cancer	0.211	1	CbGaD
Valproic Acid—SLC22A5—Dactinomycin—kidney cancer	0.0414	0.112	CbGbCtD
Valproic Acid—UGT1A9—Sorafenib—kidney cancer	0.0411	0.111	CbGbCtD
Valproic Acid—CYP3A5—Temsirolimus—kidney cancer	0.0336	0.0905	CbGbCtD
Valproic Acid—CYP3A4—Everolimus—kidney cancer	0.0194	0.0523	CbGbCtD
Valproic Acid—CYP2C8—Pazopanib—kidney cancer	0.017	0.0457	CbGbCtD
Valproic Acid—CYP1A2—Pazopanib—kidney cancer	0.0131	0.0354	CbGbCtD
Valproic Acid—CYP3A4—Temsirolimus—kidney cancer	0.0131	0.0353	CbGbCtD
Valproic Acid—CYP2B6—Sorafenib—kidney cancer	0.013	0.035	CbGbCtD
Valproic Acid—CYP3A5—Erlotinib—kidney cancer	0.0126	0.0339	CbGbCtD
Valproic Acid—CYP2C9—Capecitabine—kidney cancer	0.0124	0.0333	CbGbCtD
Valproic Acid—CYP2C8—Erlotinib—kidney cancer	0.0121	0.0326	CbGbCtD
Valproic Acid—CYP3A5—Paclitaxel—kidney cancer	0.0115	0.0311	CbGbCtD
Valproic Acid—CYP2C8—Paclitaxel—kidney cancer	0.0111	0.0299	CbGbCtD
Valproic Acid—CYP3A5—Sorafenib—kidney cancer	0.0102	0.0276	CbGbCtD
Valproic Acid—CYP3A5—Vincristine—kidney cancer	0.00995	0.0268	CbGbCtD
Valproic Acid—CYP2C8—Sorafenib—kidney cancer	0.00985	0.0265	CbGbCtD
Valproic Acid—CYP1A2—Erlotinib—kidney cancer	0.00938	0.0253	CbGbCtD
Valproic Acid—CYP3A5—Sunitinib—kidney cancer	0.0083	0.0224	CbGbCtD
Valproic Acid—CYP2C19—Sorafenib—kidney cancer	0.00826	0.0223	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—kidney cancer	0.00789	0.0212	CbGbCtD
Valproic Acid—CYP2C9—Paclitaxel—kidney cancer	0.00773	0.0208	CbGbCtD
Valproic Acid—CYP1A2—Sorafenib—kidney cancer	0.00762	0.0205	CbGbCtD
Valproic Acid—OGDH—urine—kidney cancer	0.00716	0.0832	CbGeAlD
Valproic Acid—CYP3A4—Pazopanib—kidney cancer	0.00689	0.0185	CbGbCtD
Valproic Acid—CYP2C9—Sorafenib—kidney cancer	0.00687	0.0185	CbGbCtD
Valproic Acid—CYP3A4—Erlotinib—kidney cancer	0.00491	0.0132	CbGbCtD
Valproic Acid—CYP3A4—Paclitaxel—kidney cancer	0.0045	0.0121	CbGbCtD
Valproic Acid—CYP3A4—Sorafenib—kidney cancer	0.00399	0.0108	CbGbCtD
Valproic Acid—CYP3A4—Vinblastine—kidney cancer	0.00394	0.0106	CbGbCtD
Valproic Acid—CYP3A4—Vincristine—kidney cancer	0.00388	0.0104	CbGbCtD
Valproic Acid—CYP3A4—Sunitinib—kidney cancer	0.00324	0.00872	CbGbCtD
Valproic Acid—SLC22A8—nephron—kidney cancer	0.0027	0.0314	CbGeAlD
Valproic Acid—CYP3A4—Doxorubicin—kidney cancer	0.00242	0.00653	CbGbCtD
Valproic Acid—UGT1A10—renal system—kidney cancer	0.00238	0.0277	CbGeAlD
Valproic Acid—UGT1A10—kidney—kidney cancer	0.0023	0.0268	CbGeAlD
Valproic Acid—SLC22A8—urine—kidney cancer	0.00217	0.0252	CbGeAlD
Valproic Acid—OGDH—nephron tubule—kidney cancer	0.00193	0.0224	CbGeAlD
Valproic Acid—UGT1A8—renal system—kidney cancer	0.00188	0.0219	CbGeAlD
Valproic Acid—UGT1A8—kidney—kidney cancer	0.00182	0.0212	CbGeAlD
Valproic Acid—CYP2C19—urine—kidney cancer	0.00182	0.0211	CbGeAlD
Valproic Acid—OGDH—renal system—kidney cancer	0.00175	0.0204	CbGeAlD
Valproic Acid—HDAC9—nephron tubule—kidney cancer	0.0017	0.0197	CbGeAlD
Valproic Acid—OGDH—kidney—kidney cancer	0.00169	0.0197	CbGeAlD
Valproic Acid—OGDH—cortex of kidney—kidney cancer	0.00165	0.0192	CbGeAlD
Valproic Acid—OGDH—gonad—kidney cancer	0.00157	0.0183	CbGeAlD
Valproic Acid—OGDH—cardiac atrium—kidney cancer	0.00157	0.0182	CbGeAlD
Valproic Acid—ACADSB—nephron tubule—kidney cancer	0.00153	0.0178	CbGeAlD
Valproic Acid—CYP1A2—urine—kidney cancer	0.00148	0.0172	CbGeAlD
Valproic Acid—HDAC9—cortex of kidney—kidney cancer	0.00145	0.0169	CbGeAlD
Valproic Acid—UGT1A4—renal system—kidney cancer	0.00143	0.0166	CbGeAlD
Valproic Acid—CYP2C9—urine—kidney cancer	0.00141	0.0164	CbGeAlD
Valproic Acid—ACADSB—renal system—kidney cancer	0.00139	0.0162	CbGeAlD
Valproic Acid—UGT1A4—kidney—kidney cancer	0.00138	0.016	CbGeAlD
Valproic Acid—ALDH5A1—nephron tubule—kidney cancer	0.00135	0.0157	CbGeAlD
Valproic Acid—ACADSB—kidney—kidney cancer	0.00135	0.0156	CbGeAlD
Valproic Acid—ACADSB—cortex of kidney—kidney cancer	0.00131	0.0152	CbGeAlD
Valproic Acid—ACADSB—cardiac atrium—kidney cancer	0.00125	0.0145	CbGeAlD
Valproic Acid—ALDH5A1—renal system—kidney cancer	0.00123	0.0142	CbGeAlD
Valproic Acid—UGT1A9—renal system—kidney cancer	0.0012	0.0139	CbGeAlD
Valproic Acid—ALDH5A1—kidney—kidney cancer	0.00118	0.0138	CbGeAlD
Valproic Acid—UGT1A9—kidney—kidney cancer	0.00116	0.0134	CbGeAlD
Valproic Acid—ALDH5A1—cortex of kidney—kidney cancer	0.00115	0.0134	CbGeAlD
Valproic Acid—ABAT—nephron tubule—kidney cancer	0.00115	0.0134	CbGeAlD
Valproic Acid—ALDH5A1—gonad—kidney cancer	0.0011	0.0128	CbGeAlD
Valproic Acid—ALDH5A1—cardiac atrium—kidney cancer	0.0011	0.0128	CbGeAlD
Valproic Acid—CYP3A4—urine—kidney cancer	0.00107	0.0125	CbGeAlD
Valproic Acid—ABAT—renal system—kidney cancer	0.00105	0.0122	CbGeAlD
Valproic Acid—ABAT—kidney—kidney cancer	0.00101	0.0118	CbGeAlD
Valproic Acid—ABAT—cortex of kidney—kidney cancer	0.000987	0.0115	CbGeAlD
Valproic Acid—SLC22A6—nephron tubule—kidney cancer	0.000975	0.0113	CbGeAlD
Valproic Acid—UGT2B7—renal system—kidney cancer	0.000965	0.0112	CbGeAlD
Valproic Acid—ABAT—gonad—kidney cancer	0.00094	0.0109	CbGeAlD
Valproic Acid—UGT2B7—kidney—kidney cancer	0.000933	0.0108	CbGeAlD
Valproic Acid—SLC22A7—renal system—kidney cancer	0.000918	0.0107	CbGeAlD
Valproic Acid—SLC22A7—kidney—kidney cancer	0.000887	0.0103	CbGeAlD
Valproic Acid—HDAC2—nephron tubule—kidney cancer	0.000869	0.0101	CbGeAlD
Valproic Acid—SLC22A7—cortex of kidney—kidney cancer	0.000864	0.01	CbGeAlD
Valproic Acid—SLC22A6—cortex of kidney—kidney cancer	0.000834	0.00969	CbGeAlD
Valproic Acid—ALDH5A1—Vinblastine—Vincristine—kidney cancer	0.000813	0.208	CbGdCrCtD
Valproic Acid—HDAC2—renal system—kidney cancer	0.00079	0.00917	CbGeAlD
Valproic Acid—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.000765	0.195	CbGdCrCtD
Valproic Acid—HDAC2—kidney—kidney cancer	0.000763	0.00887	CbGeAlD
Valproic Acid—HDAC2—cortex of kidney—kidney cancer	0.000744	0.00864	CbGeAlD
Valproic Acid—HDAC2—gonad—kidney cancer	0.000708	0.00823	CbGeAlD
Valproic Acid—SLC16A1—renal system—kidney cancer	0.000702	0.00815	CbGeAlD
Valproic Acid—SLC16A1—kidney—kidney cancer	0.000678	0.00788	CbGeAlD
Valproic Acid—SLC16A1—gonad—kidney cancer	0.000629	0.00731	CbGeAlD
Valproic Acid—SLC16A1—cardiac atrium—kidney cancer	0.000628	0.0073	CbGeAlD
Valproic Acid—SLC22A8—nephron tubule—kidney cancer	0.000583	0.00678	CbGeAlD
Valproic Acid—SLC22A8—renal system—kidney cancer	0.00053	0.00616	CbGeAlD
Valproic Acid—SLC22A8—kidney—kidney cancer	0.000513	0.00596	CbGeAlD
Valproic Acid—SLC22A8—cortex of kidney—kidney cancer	0.000499	0.0058	CbGeAlD
Valproic Acid—HDAC2—Temsirolimus—Everolimus—kidney cancer	0.000467	0.119	CbGdCrCtD
Valproic Acid—HDAC2—Sirolimus—Everolimus—kidney cancer	0.000467	0.119	CbGdCrCtD
Valproic Acid—HDAC2—Sirolimus—Temsirolimus—kidney cancer	0.000467	0.119	CbGdCrCtD
Valproic Acid—HDAC2—Everolimus—Temsirolimus—kidney cancer	0.000467	0.119	CbGdCrCtD
Valproic Acid—HDAC2—Gefitinib—Erlotinib—kidney cancer	0.000466	0.119	CbGdCrCtD
Valproic Acid—SLC22A5—nephron tubule—kidney cancer	0.000441	0.00512	CbGeAlD
Valproic Acid—SLC22A5—renal system—kidney cancer	0.000401	0.00466	CbGeAlD
Valproic Acid—CYP2C8—renal system—kidney cancer	0.000388	0.00451	CbGeAlD
Valproic Acid—SLC22A5—kidney—kidney cancer	0.000388	0.0045	CbGeAlD
Valproic Acid—CYP3A5—nephron tubule—kidney cancer	0.000385	0.00448	CbGeAlD
Valproic Acid—CYP2B6—nephron tubule—kidney cancer	0.000383	0.00445	CbGeAlD
Valproic Acid—SLC22A5—cortex of kidney—kidney cancer	0.000377	0.00439	CbGeAlD
Valproic Acid—CYP2C8—kidney—kidney cancer	0.000375	0.00436	CbGeAlD
Valproic Acid—CYP1A2—renal system—kidney cancer	0.000363	0.00422	CbGeAlD
Valproic Acid—SLC22A5—cardiac atrium—kidney cancer	0.000359	0.00417	CbGeAlD
Valproic Acid—CYP3A5—renal system—kidney cancer	0.00035	0.00407	CbGeAlD
Valproic Acid—CYP2B6—renal system—kidney cancer	0.000348	0.00404	CbGeAlD
Valproic Acid—CYP3A5—kidney—kidney cancer	0.000339	0.00393	CbGeAlD
Valproic Acid—CYP2B6—kidney—kidney cancer	0.000337	0.00391	CbGeAlD
Valproic Acid—CYP3A5—cortex of kidney—kidney cancer	0.00033	0.00383	CbGeAlD
Valproic Acid—PTGS1—renal system—kidney cancer	0.000315	0.00366	CbGeAlD
Valproic Acid—CYP2B6—gonad—kidney cancer	0.000312	0.00363	CbGeAlD
Valproic Acid—PTGS1—kidney—kidney cancer	0.000304	0.00354	CbGeAlD
Valproic Acid—PTGS1—cardiac atrium—kidney cancer	0.000282	0.00327	CbGeAlD
Valproic Acid—CYP3A4—renal system—kidney cancer	0.000263	0.00305	CbGeAlD
Valproic Acid—CYP3A4—kidney—kidney cancer	0.000254	0.00295	CbGeAlD
Valproic Acid—Alopecia—Capecitabine—kidney cancer	6.27e-05	0.000306	CcSEcCtD
Valproic Acid—Dry mouth—Paclitaxel—kidney cancer	6.27e-05	0.000306	CcSEcCtD
Valproic Acid—Mood swings—Doxorubicin—kidney cancer	6.27e-05	0.000305	CcSEcCtD
Valproic Acid—Diarrhoea—Sunitinib—kidney cancer	6.26e-05	0.000305	CcSEcCtD
Valproic Acid—Ataxia—Doxorubicin—kidney cancer	6.22e-05	0.000303	CcSEcCtD
Valproic Acid—Mental disorder—Capecitabine—kidney cancer	6.22e-05	0.000303	CcSEcCtD
Valproic Acid—Asthenia—Dactinomycin—kidney cancer	6.21e-05	0.000303	CcSEcCtD
Valproic Acid—Confusional state—Paclitaxel—kidney cancer	6.2e-05	0.000302	CcSEcCtD
Valproic Acid—Malnutrition—Capecitabine—kidney cancer	6.18e-05	0.000301	CcSEcCtD
Valproic Acid—Oedema—Paclitaxel—kidney cancer	6.14e-05	0.0003	CcSEcCtD
Valproic Acid—Anaphylactic shock—Paclitaxel—kidney cancer	6.14e-05	0.0003	CcSEcCtD
Valproic Acid—Abdominal pain—Vincristine—kidney cancer	6.12e-05	0.000298	CcSEcCtD
Valproic Acid—Body temperature increased—Vincristine—kidney cancer	6.12e-05	0.000298	CcSEcCtD
Valproic Acid—Infection—Paclitaxel—kidney cancer	6.1e-05	0.000298	CcSEcCtD
Valproic Acid—Flatulence—Capecitabine—kidney cancer	6.09e-05	0.000297	CcSEcCtD
Valproic Acid—Dry skin—Doxorubicin—kidney cancer	6.06e-05	0.000296	CcSEcCtD
Valproic Acid—Dysgeusia—Capecitabine—kidney cancer	6.05e-05	0.000295	CcSEcCtD
Valproic Acid—Dizziness—Sunitinib—kidney cancer	6.05e-05	0.000295	CcSEcCtD
Valproic Acid—Feeling abnormal—Gemcitabine—kidney cancer	6.05e-05	0.000295	CcSEcCtD
Valproic Acid—Vomiting—Sorafenib—kidney cancer	6.04e-05	0.000295	CcSEcCtD
Valproic Acid—Abdominal pain upper—Doxorubicin—kidney cancer	6.04e-05	0.000294	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Doxorubicin—kidney cancer	6.04e-05	0.000294	CcSEcCtD
Valproic Acid—Nervous system disorder—Paclitaxel—kidney cancer	6.03e-05	0.000294	CcSEcCtD
Valproic Acid—Thrombocytopenia—Paclitaxel—kidney cancer	6.02e-05	0.000293	CcSEcCtD
Valproic Acid—Tachycardia—Paclitaxel—kidney cancer	6e-05	0.000292	CcSEcCtD
Valproic Acid—Rash—Sorafenib—kidney cancer	5.99e-05	0.000292	CcSEcCtD
Valproic Acid—Dermatitis—Sorafenib—kidney cancer	5.99e-05	0.000292	CcSEcCtD
Valproic Acid—Back pain—Capecitabine—kidney cancer	5.98e-05	0.000291	CcSEcCtD
Valproic Acid—Breast disorder—Doxorubicin—kidney cancer	5.98e-05	0.000291	CcSEcCtD
Valproic Acid—Skin disorder—Paclitaxel—kidney cancer	5.97e-05	0.000291	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	5.96e-05	0.00029	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	5.96e-05	0.00029	CcSEcCtD
Valproic Acid—Headache—Sorafenib—kidney cancer	5.95e-05	0.00029	CcSEcCtD
Valproic Acid—Muscle spasms—Capecitabine—kidney cancer	5.94e-05	0.00029	CcSEcCtD
Valproic Acid—Hyperhidrosis—Paclitaxel—kidney cancer	5.94e-05	0.00029	CcSEcCtD
Valproic Acid—Diarrhoea—Dactinomycin—kidney cancer	5.92e-05	0.000289	CcSEcCtD
Valproic Acid—Anorexia—Paclitaxel—kidney cancer	5.86e-05	0.000286	CcSEcCtD
Valproic Acid—Muscular weakness—Doxorubicin—kidney cancer	5.83e-05	0.000284	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Doxorubicin—kidney cancer	5.83e-05	0.000284	CcSEcCtD
Valproic Acid—Vision blurred—Capecitabine—kidney cancer	5.82e-05	0.000284	CcSEcCtD
Valproic Acid—Vomiting—Sunitinib—kidney cancer	5.82e-05	0.000283	CcSEcCtD
Valproic Acid—Body temperature increased—Gemcitabine—kidney cancer	5.8e-05	0.000283	CcSEcCtD
Valproic Acid—Tremor—Capecitabine—kidney cancer	5.79e-05	0.000282	CcSEcCtD
Valproic Acid—Rash—Sunitinib—kidney cancer	5.77e-05	0.000281	CcSEcCtD
Valproic Acid—Dermatitis—Sunitinib—kidney cancer	5.76e-05	0.000281	CcSEcCtD
Valproic Acid—Hypotension—Paclitaxel—kidney cancer	5.74e-05	0.00028	CcSEcCtD
Valproic Acid—Ill-defined disorder—Capecitabine—kidney cancer	5.73e-05	0.000279	CcSEcCtD
Valproic Acid—Headache—Sunitinib—kidney cancer	5.73e-05	0.000279	CcSEcCtD
Valproic Acid—Dysphagia—Doxorubicin—kidney cancer	5.72e-05	0.000279	CcSEcCtD
Valproic Acid—Influenza—Doxorubicin—kidney cancer	5.72e-05	0.000279	CcSEcCtD
Valproic Acid—Anaemia—Capecitabine—kidney cancer	5.71e-05	0.000278	CcSEcCtD
Valproic Acid—Hypersensitivity—Vincristine—kidney cancer	5.7e-05	0.000278	CcSEcCtD
Valproic Acid—Eosinophilia—Doxorubicin—kidney cancer	5.66e-05	0.000276	CcSEcCtD
Valproic Acid—Nausea—Sorafenib—kidney cancer	5.65e-05	0.000275	CcSEcCtD
Valproic Acid—Pancreatitis—Doxorubicin—kidney cancer	5.6e-05	0.000273	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.6e-05	0.000273	CcSEcCtD
Valproic Acid—Malaise—Capecitabine—kidney cancer	5.57e-05	0.000272	CcSEcCtD
Valproic Acid—Insomnia—Paclitaxel—kidney cancer	5.56e-05	0.000271	CcSEcCtD
Valproic Acid—Vertigo—Capecitabine—kidney cancer	5.55e-05	0.000271	CcSEcCtD
Valproic Acid—Asthenia—Vincristine—kidney cancer	5.55e-05	0.000271	CcSEcCtD
Valproic Acid—Leukopenia—Capecitabine—kidney cancer	5.53e-05	0.00027	CcSEcCtD
Valproic Acid—Paraesthesia—Paclitaxel—kidney cancer	5.52e-05	0.000269	CcSEcCtD
Valproic Acid—Vomiting—Dactinomycin—kidney cancer	5.51e-05	0.000268	CcSEcCtD
Valproic Acid—Bronchitis—Doxorubicin—kidney cancer	5.5e-05	0.000268	CcSEcCtD
Valproic Acid—Dyspnoea—Paclitaxel—kidney cancer	5.48e-05	0.000267	CcSEcCtD
Valproic Acid—Somnolence—Paclitaxel—kidney cancer	5.46e-05	0.000266	CcSEcCtD
Valproic Acid—Palpitations—Capecitabine—kidney cancer	5.46e-05	0.000266	CcSEcCtD
Valproic Acid—Rash—Dactinomycin—kidney cancer	5.46e-05	0.000266	CcSEcCtD
Valproic Acid—Nausea—Sunitinib—kidney cancer	5.43e-05	0.000265	CcSEcCtD
Valproic Acid—Pancytopenia—Doxorubicin—kidney cancer	5.43e-05	0.000265	CcSEcCtD
Valproic Acid—Dyspepsia—Paclitaxel—kidney cancer	5.41e-05	0.000264	CcSEcCtD
Valproic Acid—Cough—Capecitabine—kidney cancer	5.39e-05	0.000263	CcSEcCtD
Valproic Acid—Dysuria—Doxorubicin—kidney cancer	5.34e-05	0.000261	CcSEcCtD
Valproic Acid—Neutropenia—Doxorubicin—kidney cancer	5.34e-05	0.000261	CcSEcCtD
Valproic Acid—Decreased appetite—Paclitaxel—kidney cancer	5.34e-05	0.00026	CcSEcCtD
Valproic Acid—Hypertension—Capecitabine—kidney cancer	5.33e-05	0.00026	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.3e-05	0.000259	CcSEcCtD
Valproic Acid—Fatigue—Paclitaxel—kidney cancer	5.3e-05	0.000258	CcSEcCtD
Valproic Acid—Diarrhoea—Vincristine—kidney cancer	5.29e-05	0.000258	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—kidney cancer	5.28e-05	0.000257	CcSEcCtD
Valproic Acid—Asthenia—Gemcitabine—kidney cancer	5.27e-05	0.000257	CcSEcCtD
Valproic Acid—Chest pain—Capecitabine—kidney cancer	5.26e-05	0.000256	CcSEcCtD
Valproic Acid—Myalgia—Capecitabine—kidney cancer	5.26e-05	0.000256	CcSEcCtD
Valproic Acid—Arthralgia—Capecitabine—kidney cancer	5.26e-05	0.000256	CcSEcCtD
Valproic Acid—Pain—Paclitaxel—kidney cancer	5.25e-05	0.000256	CcSEcCtD
Valproic Acid—Constipation—Paclitaxel—kidney cancer	5.25e-05	0.000256	CcSEcCtD
Valproic Acid—Anxiety—Capecitabine—kidney cancer	5.24e-05	0.000256	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.22e-05	0.000255	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—kidney cancer	5.22e-05	0.000254	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—kidney cancer	5.2e-05	0.000254	CcSEcCtD
Valproic Acid—Discomfort—Capecitabine—kidney cancer	5.2e-05	0.000253	CcSEcCtD
Valproic Acid—Pruritus—Gemcitabine—kidney cancer	5.19e-05	0.000253	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—kidney cancer	5.17e-05	0.000252	CcSEcCtD
Valproic Acid—Dry mouth—Capecitabine—kidney cancer	5.14e-05	0.000251	CcSEcCtD
Valproic Acid—Nausea—Dactinomycin—kidney cancer	5.14e-05	0.000251	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—kidney cancer	5.13e-05	0.00025	CcSEcCtD
Valproic Acid—Dizziness—Vincristine—kidney cancer	5.12e-05	0.000249	CcSEcCtD
Valproic Acid—Drowsiness—Doxorubicin—kidney cancer	5.1e-05	0.000248	CcSEcCtD
Valproic Acid—Confusional state—Capecitabine—kidney cancer	5.08e-05	0.000248	CcSEcCtD
Valproic Acid—Feeling abnormal—Paclitaxel—kidney cancer	5.06e-05	0.000247	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.05e-05	0.000246	CcSEcCtD
Valproic Acid—Oedema—Capecitabine—kidney cancer	5.04e-05	0.000246	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Paclitaxel—kidney cancer	5.02e-05	0.000245	CcSEcCtD
Valproic Acid—Diarrhoea—Gemcitabine—kidney cancer	5.02e-05	0.000245	CcSEcCtD
Valproic Acid—Infection—Capecitabine—kidney cancer	5.01e-05	0.000244	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—kidney cancer	4.97e-05	0.000242	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—kidney cancer	4.95e-05	0.000241	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—kidney cancer	4.95e-05	0.000241	CcSEcCtD
Valproic Acid—Nervous system disorder—Capecitabine—kidney cancer	4.95e-05	0.000241	CcSEcCtD
Valproic Acid—Thrombocytopenia—Capecitabine—kidney cancer	4.94e-05	0.000241	CcSEcCtD
Valproic Acid—Tachycardia—Capecitabine—kidney cancer	4.92e-05	0.00024	CcSEcCtD
Valproic Acid—Vomiting—Vincristine—kidney cancer	4.92e-05	0.00024	CcSEcCtD
Valproic Acid—Skin disorder—Capecitabine—kidney cancer	4.9e-05	0.000239	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—kidney cancer	4.89e-05	0.000238	CcSEcCtD
Valproic Acid—Urticaria—Paclitaxel—kidney cancer	4.88e-05	0.000238	CcSEcCtD
Valproic Acid—Rash—Vincristine—kidney cancer	4.88e-05	0.000238	CcSEcCtD
Valproic Acid—Hyperhidrosis—Capecitabine—kidney cancer	4.87e-05	0.000238	CcSEcCtD
Valproic Acid—Dermatitis—Vincristine—kidney cancer	4.87e-05	0.000238	CcSEcCtD
Valproic Acid—Abdominal pain—Paclitaxel—kidney cancer	4.86e-05	0.000237	CcSEcCtD
Valproic Acid—Body temperature increased—Paclitaxel—kidney cancer	4.86e-05	0.000237	CcSEcCtD
Valproic Acid—Headache—Vincristine—kidney cancer	4.85e-05	0.000236	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—kidney cancer	4.82e-05	0.000235	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—kidney cancer	4.81e-05	0.000234	CcSEcCtD
Valproic Acid—Anorexia—Capecitabine—kidney cancer	4.81e-05	0.000234	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—kidney cancer	4.78e-05	0.000233	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—kidney cancer	4.76e-05	0.000232	CcSEcCtD
Valproic Acid—Hypotension—Capecitabine—kidney cancer	4.71e-05	0.00023	CcSEcCtD
Valproic Acid—Vomiting—Gemcitabine—kidney cancer	4.67e-05	0.000227	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—kidney cancer	4.66e-05	0.000227	CcSEcCtD
Valproic Acid—Rash—Gemcitabine—kidney cancer	4.63e-05	0.000226	CcSEcCtD
Valproic Acid—Dermatitis—Gemcitabine—kidney cancer	4.62e-05	0.000225	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—kidney cancer	4.6e-05	0.000224	CcSEcCtD
Valproic Acid—Headache—Gemcitabine—kidney cancer	4.6e-05	0.000224	CcSEcCtD
Valproic Acid—Nausea—Vincristine—kidney cancer	4.6e-05	0.000224	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.59e-05	0.000224	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—kidney cancer	4.59e-05	0.000224	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—kidney cancer	4.58e-05	0.000223	CcSEcCtD
Valproic Acid—Insomnia—Capecitabine—kidney cancer	4.56e-05	0.000222	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—kidney cancer	4.55e-05	0.000222	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—kidney cancer	4.54e-05	0.000221	CcSEcCtD
Valproic Acid—Paraesthesia—Capecitabine—kidney cancer	4.53e-05	0.000221	CcSEcCtD
Valproic Acid—Hypersensitivity—Paclitaxel—kidney cancer	4.53e-05	0.000221	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—kidney cancer	4.52e-05	0.00022	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—kidney cancer	4.51e-05	0.00022	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—kidney cancer	4.5e-05	0.000219	CcSEcCtD
Valproic Acid—Dyspnoea—Capecitabine—kidney cancer	4.5e-05	0.000219	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—kidney cancer	4.48e-05	0.000219	CcSEcCtD
Valproic Acid—Dyspepsia—Capecitabine—kidney cancer	4.44e-05	0.000216	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—kidney cancer	4.41e-05	0.000215	CcSEcCtD
Valproic Acid—Asthenia—Paclitaxel—kidney cancer	4.41e-05	0.000215	CcSEcCtD
Valproic Acid—Decreased appetite—Capecitabine—kidney cancer	4.38e-05	0.000214	CcSEcCtD
Valproic Acid—Nausea—Gemcitabine—kidney cancer	4.36e-05	0.000213	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Capecitabine—kidney cancer	4.35e-05	0.000212	CcSEcCtD
Valproic Acid—Fatigue—Capecitabine—kidney cancer	4.35e-05	0.000212	CcSEcCtD
Valproic Acid—Pruritus—Paclitaxel—kidney cancer	4.35e-05	0.000212	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—kidney cancer	4.33e-05	0.000211	CcSEcCtD
Valproic Acid—Constipation—Capecitabine—kidney cancer	4.31e-05	0.00021	CcSEcCtD
Valproic Acid—Pain—Capecitabine—kidney cancer	4.31e-05	0.00021	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—kidney cancer	4.28e-05	0.000208	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—kidney cancer	4.27e-05	0.000208	CcSEcCtD
Valproic Acid—Diarrhoea—Paclitaxel—kidney cancer	4.2e-05	0.000205	CcSEcCtD
Valproic Acid—Feeling abnormal—Capecitabine—kidney cancer	4.16e-05	0.000203	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—kidney cancer	4.15e-05	0.000202	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—kidney cancer	4.13e-05	0.000201	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Capecitabine—kidney cancer	4.12e-05	0.000201	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—kidney cancer	4.12e-05	0.000201	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—kidney cancer	4.11e-05	0.0002	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—kidney cancer	4.09e-05	0.000199	CcSEcCtD
Valproic Acid—Dizziness—Paclitaxel—kidney cancer	4.06e-05	0.000198	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—kidney cancer	4.04e-05	0.000197	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—kidney cancer	4.01e-05	0.000195	CcSEcCtD
Valproic Acid—Urticaria—Capecitabine—kidney cancer	4.01e-05	0.000195	CcSEcCtD
Valproic Acid—Abdominal pain—Capecitabine—kidney cancer	3.99e-05	0.000194	CcSEcCtD
Valproic Acid—Body temperature increased—Capecitabine—kidney cancer	3.99e-05	0.000194	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—kidney cancer	3.98e-05	0.000194	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—kidney cancer	3.92e-05	0.000191	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—kidney cancer	3.91e-05	0.000191	CcSEcCtD
Valproic Acid—Vomiting—Paclitaxel—kidney cancer	3.91e-05	0.00019	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—kidney cancer	3.9e-05	0.00019	CcSEcCtD
Valproic Acid—Rash—Paclitaxel—kidney cancer	3.87e-05	0.000189	CcSEcCtD
Valproic Acid—Dermatitis—Paclitaxel—kidney cancer	3.87e-05	0.000189	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—kidney cancer	3.87e-05	0.000189	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—kidney cancer	3.85e-05	0.000188	CcSEcCtD
Valproic Acid—Headache—Paclitaxel—kidney cancer	3.85e-05	0.000188	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—kidney cancer	3.83e-05	0.000187	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—kidney cancer	3.75e-05	0.000183	CcSEcCtD
Valproic Acid—Hypersensitivity—Capecitabine—kidney cancer	3.72e-05	0.000181	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—kidney cancer	3.7e-05	0.00018	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—kidney cancer	3.68e-05	0.000179	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—kidney cancer	3.66e-05	0.000178	CcSEcCtD
Valproic Acid—Nausea—Paclitaxel—kidney cancer	3.65e-05	0.000178	CcSEcCtD
Valproic Acid—Asthenia—Capecitabine—kidney cancer	3.62e-05	0.000176	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—kidney cancer	3.59e-05	0.000175	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—kidney cancer	3.58e-05	0.000174	CcSEcCtD
Valproic Acid—Pruritus—Capecitabine—kidney cancer	3.57e-05	0.000174	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—kidney cancer	3.57e-05	0.000174	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—kidney cancer	3.52e-05	0.000172	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—kidney cancer	3.48e-05	0.000169	CcSEcCtD
Valproic Acid—Diarrhoea—Capecitabine—kidney cancer	3.45e-05	0.000168	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—kidney cancer	3.44e-05	0.000168	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—kidney cancer	3.39e-05	0.000165	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—kidney cancer	3.39e-05	0.000165	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—kidney cancer	3.39e-05	0.000165	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—kidney cancer	3.38e-05	0.000165	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.37e-05	0.000164	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—kidney cancer	3.35e-05	0.000163	CcSEcCtD
Valproic Acid—Dizziness—Capecitabine—kidney cancer	3.33e-05	0.000163	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—kidney cancer	3.32e-05	0.000162	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—kidney cancer	3.28e-05	0.00016	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—kidney cancer	3.25e-05	0.000158	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—kidney cancer	3.25e-05	0.000158	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—kidney cancer	3.23e-05	0.000157	CcSEcCtD
Valproic Acid—Vomiting—Capecitabine—kidney cancer	3.21e-05	0.000156	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—kidney cancer	3.19e-05	0.000155	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—kidney cancer	3.18e-05	0.000155	CcSEcCtD
Valproic Acid—Rash—Capecitabine—kidney cancer	3.18e-05	0.000155	CcSEcCtD
Valproic Acid—Dermatitis—Capecitabine—kidney cancer	3.18e-05	0.000155	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—kidney cancer	3.17e-05	0.000155	CcSEcCtD
Valproic Acid—Headache—Capecitabine—kidney cancer	3.16e-05	0.000154	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—kidney cancer	3.16e-05	0.000154	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—kidney cancer	3.14e-05	0.000153	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—kidney cancer	3.1e-05	0.000151	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—kidney cancer	3.04e-05	0.000148	CcSEcCtD
Valproic Acid—Nausea—Capecitabine—kidney cancer	3e-05	0.000146	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.96e-05	0.000144	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—kidney cancer	2.94e-05	0.000143	CcSEcCtD
Valproic Acid—Paraesthesia—Doxorubicin—kidney cancer	2.92e-05	0.000142	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—kidney cancer	2.9e-05	0.000141	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—kidney cancer	2.89e-05	0.000141	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—kidney cancer	2.86e-05	0.000139	CcSEcCtD
Valproic Acid—Decreased appetite—Doxorubicin—kidney cancer	2.83e-05	0.000138	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.81e-05	0.000137	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—kidney cancer	2.8e-05	0.000137	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—kidney cancer	2.78e-05	0.000135	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—kidney cancer	2.78e-05	0.000135	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—kidney cancer	2.68e-05	0.000131	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Doxorubicin—kidney cancer	2.66e-05	0.00013	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—kidney cancer	2.58e-05	0.000126	CcSEcCtD
Valproic Acid—Abdominal pain—Doxorubicin—kidney cancer	2.57e-05	0.000125	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—kidney cancer	2.57e-05	0.000125	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—kidney cancer	2.39e-05	0.000117	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—kidney cancer	2.33e-05	0.000114	CcSEcCtD
Valproic Acid—Pruritus—Doxorubicin—kidney cancer	2.3e-05	0.000112	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—kidney cancer	2.22e-05	0.000108	CcSEcCtD
Valproic Acid—Dizziness—Doxorubicin—kidney cancer	2.15e-05	0.000105	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—kidney cancer	2.07e-05	0.000101	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—kidney cancer	2.05e-05	9.99e-05	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—kidney cancer	2.05e-05	9.98e-05	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—kidney cancer	2.04e-05	9.93e-05	CcSEcCtD
Valproic Acid—Nausea—Doxorubicin—kidney cancer	1.93e-05	9.41e-05	CcSEcCtD
Valproic Acid—CYP1A2—Metabolism—ALAD—kidney cancer	6.45e-06	5.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CA9—kidney cancer	6.43e-06	5.24e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—POMC—kidney cancer	6.43e-06	5.24e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SLC2A1—kidney cancer	6.32e-06	5.15e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ST3GAL2—kidney cancer	6.29e-06	5.13e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.29e-06	5.12e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HIF1A—kidney cancer	6.29e-06	5.12e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GSTM1—kidney cancer	6.29e-06	5.12e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TSC2—kidney cancer	6.27e-06	5.11e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RAF1—kidney cancer	6.21e-06	5.06e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—kidney cancer	6.17e-06	5.03e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALDH1A1—kidney cancer	6.15e-06	5.01e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ERBB2—kidney cancer	6.14e-06	5.01e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTT1—kidney cancer	6.14e-06	5e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ACHE—kidney cancer	6.14e-06	5e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CRABP1—kidney cancer	6.13e-06	4.99e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MTOR—kidney cancer	6.06e-06	4.94e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CD4—kidney cancer	6.05e-06	4.93e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KDR—kidney cancer	6.01e-06	4.9e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—kidney cancer	6.01e-06	4.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPAT—kidney cancer	6e-06	4.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GLIPR1—kidney cancer	6e-06	4.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ACHE—kidney cancer	6e-06	4.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTT1—kidney cancer	6e-06	4.89e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PIK3CA—kidney cancer	5.97e-06	4.86e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP1A1—kidney cancer	5.96e-06	4.86e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC5A3—kidney cancer	5.9e-06	4.8e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PGK1—kidney cancer	5.9e-06	4.8e-05	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PIK3CA—kidney cancer	5.89e-06	4.8e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CA9—kidney cancer	5.87e-06	4.78e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SCARB1—kidney cancer	5.81e-06	4.73e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—LDHB—kidney cancer	5.78e-06	4.71e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—kidney cancer	5.77e-06	4.7e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS1—kidney cancer	5.75e-06	4.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.73e-06	4.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ITPR2—kidney cancer	5.7e-06	4.64e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CDKN1B—kidney cancer	5.69e-06	4.64e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SCARB1—kidney cancer	5.68e-06	4.63e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.66e-06	4.61e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PSMD7—kidney cancer	5.64e-06	4.6e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS1—kidney cancer	5.62e-06	4.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—POMC—kidney cancer	5.62e-06	4.58e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—FH—kidney cancer	5.58e-06	4.55e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APRT—kidney cancer	5.58e-06	4.55e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GSTP1—kidney cancer	5.58e-06	4.54e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—APC—kidney cancer	5.54e-06	4.51e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KIT—kidney cancer	5.54e-06	4.51e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PSMD7—kidney cancer	5.51e-06	4.49e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—kidney cancer	5.5e-06	4.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CRABP1—kidney cancer	5.47e-06	4.46e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—POMC—kidney cancer	5.47e-06	4.46e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTEN—kidney cancer	5.38e-06	4.38e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CTNNB1—kidney cancer	5.37e-06	4.38e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—BCHE—kidney cancer	5.35e-06	4.36e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC5A5—kidney cancer	5.28e-06	4.3e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ABCB1—kidney cancer	5.28e-06	4.3e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GSTP1—kidney cancer	5.27e-06	4.3e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—POMC—kidney cancer	5.27e-06	4.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.25e-06	4.28e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPC3—kidney cancer	5.25e-06	4.28e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTEN—kidney cancer	5.24e-06	4.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—BCHE—kidney cancer	5.23e-06	4.26e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—BRAF—kidney cancer	5.21e-06	4.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ACHE—kidney cancer	5.2e-06	4.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTT1—kidney cancer	5.2e-06	4.23e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC5A5—kidney cancer	5.16e-06	4.21e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—kidney cancer	5.13e-06	4.18e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GSTM1—kidney cancer	5.12e-06	4.18e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CA2—kidney cancer	5.11e-06	4.16e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC2A1—kidney cancer	5.1e-06	4.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ITPR2—kidney cancer	5.09e-06	4.14e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CA9—kidney cancer	5.01e-06	4.09e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ABCB1—kidney cancer	4.99e-06	4.07e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CRABP1—kidney cancer	4.99e-06	4.07e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC2A1—kidney cancer	4.99e-06	4.06e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALAD—kidney cancer	4.98e-06	4.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SCARB1—kidney cancer	4.92e-06	4.01e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PIK3CA—kidney cancer	4.92e-06	4.01e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.9e-06	3.99e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.9e-06	3.99e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS1—kidney cancer	4.87e-06	3.97e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP1A1—kidney cancer	4.86e-06	3.96e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.86e-06	3.96e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GSTM1—kidney cancer	4.85e-06	3.95e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MAPK3—kidney cancer	4.82e-06	3.93e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTEN—kidney cancer	4.8e-06	3.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PSMD7—kidney cancer	4.78e-06	3.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.75e-06	3.87e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.69e-06	3.82e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—kidney cancer	4.69e-06	3.82e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTT1—kidney cancer	4.64e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ACHE—kidney cancer	4.64e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ITPR2—kidney cancer	4.64e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP1A1—kidney cancer	4.59e-06	3.74e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PGK1—kidney cancer	4.55e-06	3.71e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.55e-06	3.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—BCHE—kidney cancer	4.53e-06	3.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—kidney cancer	4.48e-06	3.65e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK3—kidney cancer	4.48e-06	3.65e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTEN—kidney cancer	4.47e-06	3.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC5A5—kidney cancer	4.47e-06	3.64e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LDHB—kidney cancer	4.46e-06	3.64e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—POMC—kidney cancer	4.44e-06	3.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SCARB1—kidney cancer	4.39e-06	3.58e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—kidney cancer	4.36e-06	3.55e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—kidney cancer	4.35e-06	3.55e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RAF1—kidney cancer	4.35e-06	3.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS1—kidney cancer	4.35e-06	3.54e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RELA—kidney cancer	4.33e-06	3.53e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC2A1—kidney cancer	4.32e-06	3.52e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB2—kidney cancer	4.3e-06	3.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.28e-06	3.48e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CRABP1—kidney cancer	4.26e-06	3.47e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PSMD7—kidney cancer	4.26e-06	3.47e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK1—kidney cancer	4.26e-06	3.47e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTP1—kidney cancer	4.25e-06	3.47e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MTOR—kidney cancer	4.24e-06	3.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ACHE—kidney cancer	4.23e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTT1—kidney cancer	4.23e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.19e-06	3.41e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTP1—kidney cancer	4.16e-06	3.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—BCHE—kidney cancer	4.04e-06	3.29e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ABCB1—kidney cancer	4.03e-06	3.28e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—kidney cancer	4.02e-06	3.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SCARB1—kidney cancer	4e-06	3.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.99e-06	3.25e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.99e-06	3.25e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1B—kidney cancer	3.98e-06	3.25e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ITPR2—kidney cancer	3.96e-06	3.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS1—kidney cancer	3.96e-06	3.23e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ABCB1—kidney cancer	3.94e-06	3.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—kidney cancer	3.91e-06	3.19e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTM1—kidney cancer	3.91e-06	3.19e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—kidney cancer	3.9e-06	3.18e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PSMD7—kidney cancer	3.89e-06	3.17e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CA9—kidney cancer	3.87e-06	3.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.85e-06	3.14e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTM1—kidney cancer	3.82e-06	3.11e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—kidney cancer	3.8e-06	3.1e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—kidney cancer	3.8e-06	3.1e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—kidney cancer	3.8e-06	3.09e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—JUN—kidney cancer	3.79e-06	3.09e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CTNNB1—kidney cancer	3.76e-06	3.07e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.74e-06	3.05e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP1A1—kidney cancer	3.71e-06	3.02e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—kidney cancer	3.7e-06	3.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—BCHE—kidney cancer	3.68e-06	3e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—kidney cancer	3.67e-06	2.99e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.65e-06	2.98e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.65e-06	2.98e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.64e-06	2.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP1A1—kidney cancer	3.62e-06	2.95e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—POMC—kidney cancer	3.62e-06	2.95e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTT1—kidney cancer	3.61e-06	2.94e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ACHE—kidney cancer	3.61e-06	2.94e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTP1—kidney cancer	3.6e-06	2.94e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—kidney cancer	3.54e-06	2.89e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.51e-06	2.86e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—POMC—kidney cancer	3.42e-06	2.79e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SCARB1—kidney cancer	3.42e-06	2.79e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.41e-06	2.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ABCB1—kidney cancer	3.41e-06	2.78e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS1—kidney cancer	3.39e-06	2.76e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—kidney cancer	3.38e-06	2.76e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PSMD7—kidney cancer	3.32e-06	2.71e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—kidney cancer	3.31e-06	2.7e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTM1—kidney cancer	3.31e-06	2.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CRABP1—kidney cancer	3.29e-06	2.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.26e-06	2.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTP1—kidney cancer	3.22e-06	2.62e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—kidney cancer	3.16e-06	2.57e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—BCHE—kidney cancer	3.15e-06	2.57e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.14e-06	2.56e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK3—kidney cancer	3.13e-06	2.55e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.11e-06	2.53e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—kidney cancer	3.09e-06	2.52e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ITPR2—kidney cancer	3.06e-06	2.49e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—kidney cancer	3.05e-06	2.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ABCB1—kidney cancer	3.04e-06	2.48e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC2A1—kidney cancer	3e-06	2.45e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK1—kidney cancer	2.98e-06	2.43e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.97e-06	2.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTM1—kidney cancer	2.95e-06	2.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTP1—kidney cancer	2.93e-06	2.39e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.91e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—kidney cancer	2.89e-06	2.35e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—kidney cancer	2.82e-06	2.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.8e-06	2.28e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTT1—kidney cancer	2.79e-06	2.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ACHE—kidney cancer	2.79e-06	2.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ABCB1—kidney cancer	2.77e-06	2.26e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—POMC—kidney cancer	2.76e-06	2.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—kidney cancer	2.76e-06	2.25e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—kidney cancer	2.73e-06	2.23e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—POMC—kidney cancer	2.7e-06	2.2e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTM1—kidney cancer	2.69e-06	2.2e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—kidney cancer	2.68e-06	2.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SCARB1—kidney cancer	2.64e-06	2.15e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS1—kidney cancer	2.61e-06	2.13e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—kidney cancer	2.59e-06	2.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.58e-06	2.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PSMD7—kidney cancer	2.56e-06	2.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.55e-06	2.08e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.54e-06	2.07e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—kidney cancer	2.52e-06	2.05e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTP1—kidney cancer	2.51e-06	2.04e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—kidney cancer	2.5e-06	2.04e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BCHE—kidney cancer	2.43e-06	1.98e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.4e-06	1.96e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—kidney cancer	2.38e-06	1.94e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCB1—kidney cancer	2.37e-06	1.93e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—POMC—kidney cancer	2.34e-06	1.91e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.32e-06	1.89e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTM1—kidney cancer	2.3e-06	1.88e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.3e-06	1.87e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—kidney cancer	2.2e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.18e-06	1.78e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—kidney cancer	2.18e-06	1.78e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—kidney cancer	2.15e-06	1.76e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.1e-06	1.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—POMC—kidney cancer	2.09e-06	1.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTP1—kidney cancer	1.93e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—kidney cancer	1.92e-06	1.57e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—POMC—kidney cancer	1.9e-06	1.55e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—kidney cancer	1.88e-06	1.53e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—kidney cancer	1.87e-06	1.52e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCB1—kidney cancer	1.83e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.79e-06	1.46e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—kidney cancer	1.78e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTM1—kidney cancer	1.78e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.68e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.68e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—kidney cancer	1.67e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—kidney cancer	1.63e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—POMC—kidney cancer	1.63e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—kidney cancer	1.52e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—kidney cancer	1.45e-06	1.18e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.36e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.33e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—kidney cancer	1.32e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—kidney cancer	1.3e-06	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—POMC—kidney cancer	1.26e-06	1.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.15e-06	9.36e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—kidney cancer	1.13e-06	9.22e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.02e-06	8.35e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—kidney cancer	1e-06	8.16e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—kidney cancer	9.34e-07	7.61e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—kidney cancer	8.73e-07	7.12e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—kidney cancer	7.98e-07	6.51e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.16e-07	5.02e-06	CbGpPWpGaD
